Absci to participate in the stifel healthcare conference

Vancouver, wash. and new york, nov. 02, 2022 (globe newswire) -- absci corporation (nasdaq: absi), leaders in the protein drug creation revolution harnessing generative ai and scalable biological data to design better therapeutics, faster, today announced the company will be participating in the upcoming stifel healthcare conference in new york, ny.
ABSI Ratings Summary
ABSI Quant Ranking